Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders' Equity (Deficiency)

v3.10.0.1
Consolidated Statements of Shareholders' Equity (Deficiency) - CAD ($)
Capital Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance at Nov. 30, 2015 $ 21,481,242 $ 30,969,093 $ 284,421 $ (52,872,442) $ (137,686)
Balance, shares at Nov. 30, 2015 24,244,050        
Share issuance cost (Note 10) $ (1,002,655) (158,736)     (1,161,391)
Stock options to employees   2,261,444     2,261,444
DSU's to non-management board members   31,628     31,628
Shares issued for options exercised (Note 11) $ 87,259 (34,391)     $ 52,868
Shares issued for options exercised (Note 11), shares 2,750       (2,750)
Proceeds from at-the-market financing (Note 10) $ 3,469,449       $ 3,469,449
Proceeds from at-the-market financing (Note 10), shares 147,126        
Proceeds from issuance of shares and warrants (Note 10 & 14) $ 4,764,777 1,175,190     5,939,967
Proceeds from issuance of shares and warrants (Note 10 & 14), shares 368,927        
Issuance of shares on exercise of warrants (Note 14) $ 1,030,719 (330,066)     700,653
Issuance of shares on exercise of warrants (Note 14), shares 35,791        
Modification of convertible debt (Note 7)   102,909     102,909
Net loss       (10,143,577) (10,143,577)
Ending balance at Nov. 30, 2016 $ 29,830,791 34,017,071 284,421 (63,016,019) 1,116,264
Balance, shares at Nov. 30, 2016 2,978,999        
Share issuance cost (Note 10)   (685,319) (108,912)   (794,231)
Stock options to employees   1,749,999     1,749,999
DSU's to non-management board members   30,355     30,355
Shares issued for options exercised (Note 11) $ 1,100 642     $ 1,742
Shares issued for options exercised (Note 11), shares 200       200
Proceeds from at-the-market financing (Note 10) $ 2,541,640       $ 2,541,640
Proceeds from at-the-market financing (Note 10), shares 110,815        
Proceeds from issuance of shares and warrants (Note 10 & 14) $ 3,257,445 742,555     4,000,000
Proceeds from issuance of shares and warrants (Note 10 & 14), shares 363,636        
Cost of warrants issued to placement agent (Note 14)   (86,196) 86,196   0
Issuance of shares on exercise of warrants (Note 14) $ 430,573 (106,315)     324,258
Issuance of shares on exercise of warrants (Note 14), shares 16,801        
Modification of convertible debt (Note 7)   273,796     273,796
Net loss       (8,857,440) (8,857,440)
Ending balance at Nov. 30, 2017 $ 35,290,034 36,685,387 284,421 (71,873,459) 386,383
Balance, shares at Nov. 30, 2017 3,470,451        
Share issuance cost (Note 10) $ (736,652) (2,568,321)     (3,304,973)
Stock options to employees   927,686     927,686
DSU's to non-management board members   7,565     $ 7,565
Shares issued for options exercised (Note 11), shares        
Proceeds from issuance of shares and warrants (Note 10 & 14) $ 5,993,472 13,651,434     $ 19,644,906
Proceeds from issuance of shares and warrants (Note 10 & 14), shares 3,658,564        
Proceeds from exercise of Pre-Funded Warrants (Note 14) $ 4,012,528 (3,901,275)     111,253
Proceeds from exercise of Pre-Funded Warrants (Note 14), shares 11,123,334        
Shares to be issued from exercise of Pre-Funded Warrants (Note 10 & 14) $ 371,551 (361,251)     10,300
Cost of warrants issued to placement agent (Note 14) $ (602,981) 602,981      
Issuance of shares on exercise of warrants (Note 14)   0     0
Beneficial conversion feature related to convertible debenture (Note 7)   66,667     66,667
Net loss       (13,747,480) (13,747,480)
Rounding of fractional shares after consolidation (Note 2) (106)        
Ending balance at Nov. 30, 2018 $ 44,327,952 $ 45,110,873 $ 284,421 $ (85,620,939) $ 4,102,307
Balance, shares at Nov. 30, 2018 18,252,243